The Prognosis in Palliative care Study II (PiPS2): A prospective observational validation study of a prognostic tool with an embedded qualitative evaluation

P.C. Stone*, Matthew Maddocks, A Kalpakidou, C Todd, J Griffiths, V. Keeley, K. Spencer, P. Buckle, D. Finlay, V. Vickerstaff, R Z Omar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)
15 Downloads (Pure)

Abstract

Prognosis in Palliative care Study (PiPS) models predict survival probabilities in advanced cancer. PiPS-A (clinical observations only) and PiPS-B (additionally requiring blood results) consist of 14- and 56-day models (PiPS-A14; PiPS-A56; PiPS-B14; PiPS-B56) to create survival risk categories: days, weeks, months. The primary aim was to compare PIPS-B risk categories against agreed multi-professional estimates of survival (AMPES) and to validate PiPS-A and PiPS-B. Secondary aims were to assess acceptability of PiPS to patients, caregivers and health professionals (HPs).
Original languageEnglish
JournalPLoS One
Volume16
Issue number4
Publication statusPublished - 28 Apr 2021

Fingerprint

Dive into the research topics of 'The Prognosis in Palliative care Study II (PiPS2): A prospective observational validation study of a prognostic tool with an embedded qualitative evaluation'. Together they form a unique fingerprint.

Cite this